European Union - English - EMA (European Medicines Agency)

cheplapharm arzneimittel gmbh - verteporfin - myopia, degenerative; macular degeneration - ophthalmologicals - visudyne is indicated for the treatment of:adults with exudative (wet) age-related macular degeneration (amd) with predominantly classic subfoveal choroidal neovascularisation (cnv) or;adults with subfoveal choroidal neovascularisation secondary to pathological myopia.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis pharmaceuticals uk ltd - verteporfin - powder for solution for infusion - 15mg

Singapore - English - HSA (Health Sciences Authority)

zuellig pharma pte. ltd. - verteporfin - injection - 15 mg/vial - verteporfin 15 mg/vial

Canada - English - Health Canada

cheplapharm arzneimittel gmbh - verteporfin - powder for solution - 15mg - verteporfin 15mg - eent drugs, miscellaneous

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

novartis - verteporfin - powder for solution for infusion - 15 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

neon healthcare ltd - verteporfin - powder for solution for infusion - 15mg